Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cross-over clamp study of dapagliflozin, saxagliptin, and their combination in type 2 diabetes
2015-004637-27Phase 2Completed
- Sponsor
- Medical University of Graz
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dapagliflozin, saxagliptin and metformin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Medical University of Graz. Primary endpoint: ΔGlucagon. Started Dec 2015; status: completed.
02
Drugs
dapagliflozinsaxagliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-004637-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004637-27.